Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab
RAPT Therapeutics, Inc.
RAPT Therapeutics, Inc.
Presage Biosciences
Icahn School of Medicine at Mount Sinai
Corvus Pharmaceuticals, Inc.
Rutgers, The State University of New Jersey
Seagen Inc.